Skip to main content Accessibility help
  • Print publication year: 2014
  • Online publication date: August 2014

Chapter 18 - Breastfeeding and use of antiepileptics

Related content

Powered by UNSILO


1. Tomson T and Battino D. Antiepileptic treatment in pregnant women: morphological and behavioural effects. In: Seyberth HW, Rane A and Schwab M, eds. Pediatric clinical pharmacology, handbook of experimental pharmacology 205. Berlin, Heidelberg: Springer Verlag, 2011; 295–315.
2. Pennell PB. 2005 AES annual course: evidence used to treat women with epilepsy. Epilepsia 2006; 47(Suppl 1):46–53.
3. Harden CL, Meador KJ, Pennell PB, et al. Practice parameter update: management issues for women with epilepsy-focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes. Neurology 2009; 73:133–41.
4. Ip S, Chung M, Raman G, et al. A summary of the Agency for Healthcare Research and Quality’s evidence report on breastfeeding in developed countries. Breastfeed Med 2009; 4:S17–S30.
5. Kramer MS, Aboud F, Mironova E, et al. Breastfeeding and child cognitive development: new evidence from a large randomized trial. Arch Gen Psychiatry 2008; 65:578–84.
6. Ilett KF and Kristensen JH. Drug use and breastfeeding. Expert Opin Drug Saf 2005; 4:745–68.
7. Ito S and Lee A. Drug excretion into breast milk-overview. Adv Drug Deliv Rev 2003; 55:617–27.
8. Bar-Oz B, Nulman I, Koren G, et al. Anticonvulsants and breast feeding: a critical review. Paediatr Drugs 2000; 2:113–26.
9. Hovinga CA and Pennell PB. Antiepileptic drug therapy in pregnancy II: fetal and neonatal exposure. Int Rev Neurobiol 2008; 83:241–58.
10. Stika C and Frederiksen M. Drug therapy in pregnant and nursing women. In: Atkinson AJ, Abernethy D, Daniels C, et al., eds. Principles of clinical pharmacology. Burlington, VT: Academic Press, 2007; 339–57.
11. Ito S. Drug therapy for breast-feeding women. New Eng J Med 2000; 343:118–26.
12. McNamara PJ and Abbassi M. Neonatal exposure to drugs in breast milk. Pharm Res 2004; 21:555–66.
13. Anker JN, Schwab M and Kearns GL. Developmental pharmacokinetics. In: Seyberth HW, Rane A and Schwab M, eds. Pediatric clinical pharmacology, handbook of experimental pharmacology 205. Berlin, Heidelberg: Verlag Springer, 2011; 51–75.
14. Kearns GL, Abdel-Rahman SM, Alander SW, et al. Developmental pharmacology-drug disposition, action, and therapy in infants and children. New Eng J Med 2003; 349:1157–67.
15. Anderson Gail D. Children versus adults: pharmacokinetic and adverse-effect differences. Epilepsia 2002; 43:53–9.
16.Drug and lactation database (LactMed).
17. Ito S and Koren G. A novel index for expressing exposure of the infant to drugs in breast milk. Br J Clin Pharmacol 1994; 38: 99–102.
18. Bhutta ZA, Chopra M, Axelson H, et al. Countdown to 2015 decade report (2000–10): taking stock of maternal, newborn, and child survival. Lancet 2010; 375:2032–44.
19. Callen J and Pinelli J. Incidence and duration of breastfeeding for term infants in Canada, United States, Europe, and Australia: a literature review. Birth 2004; 31:285–92.
20. Ito S, Lieu M, Chan W, et al. Continuing drug therapy while breastfeeding. Part 1. Common misconceptions of patients. Can Fam Physician 1999; 45:897–9.
21. Ito S, Moretti M, Liau M, et al. Initiation and duration of breast-feeding in women receiving antiepileptics. Am J Obstet Gynecol 1995; 172:881–6.
22. Meador KJ, Baker GA, Browning N, et al. Effects of breastfeeding in children of women taking antiepileptic drugs. Neurology 2010; 75:1954–60.
23. Abdel-Latif ME, Pinner J, Clews S, et al. Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics 2006; 117:e1163–e9.
24. Hagg S and Spigset O. Anticonvulsant use during lactation. Drug Saf 2000; 22:425–40.
25. Madadi P and Ito S. Perinatal exposure to maternal lamotrigine: clinical considerations for the mother and child. Can Fam Physician 2010; 56:1132–4.